13F reference period
Q2 2026
Security Snapshot
NEPHROS INC - Common stock, par value $0.001 per share (NEPH) Institutional Ownership
CUSIP: 640671400
13F Institutional Holders and Ownership History from Q3 2019 to Q3 2026
Institutions Reporting
33
Shares (Excl. Options)
5.31M
Full value: 5,313,140 · shares · 30 Jun 2026Price
$3.57
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, par value $0.001 per share
- Symbol
- NEPH on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 5,313,140
- Total 13F value
- $18,968,047
- Portfolio coverage rank
- 0%
- Share change
- -57,139
- Value change
- -$195,903
- Number of holders
- 33
- Shares outstanding
- 10,851,408
- SEC-reported price per share
- $3.71
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- NEPH - NEPHROS INC - Common stock, par value $0.001 per share is tracked under CUSIP 640671400.
- 33 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 27 to 33 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$16M
Full value: $16,003,262 · USD · 31 Mar 2026.$18.97M
Full value: $18,968,047 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 33 institutions filings for Q2 2026.
Security key
640671400
13F reference period
Q2 2026
13F holders
33
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
NEPH full holder history
NEPHROS INC SEC filings
NEPHROS INC company facts
NEPHROS INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 640671400:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
NEPH
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| DAVIDSON CHARLES E | 5.7% | $2,807,100 | 616,945 | Charles E. Davidson | 14 Sep 2026 | |||
| Topline Capital Management, LLC | 5.6% | $2,815,930 | 595,334 | Topline Capital Management, LLC | 04 Aug 2025 | |||
| WEXFORD CAPITAL LP | 2.1% | $1,017,102 | 223,539 | Wexford Capital LP | 14 Sep 2026 |
As of 30 Jun 2026,
33
institutional investors reported holding
shares of
NEPHROS INC - Common stock, par value $0.001 per share (NEPH).
This represents
49%
of the company’s total
outstanding shares.
5.31M
Full value: 5,313,140 · shares · 30 Jun 202610.85M
Full value: 10,851,408 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
49%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| WEXFORD CAPITAL LP | 33% | 3,600,552 | 0% | 1.8% | $12,853,971 |
| Topline Capital Management, LLC | 4.9% | 535,698 | -8% | 0.5% | $1,912,442 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.8% | 198,643 | 0% | 0% | $709,156 |
| MORGAN STANLEY | 1.2% | 128,915 | +16% | 0% | $460,227 |
| Cornerstone Capital, Inc. | 1.2% | 128,700 | 0% | 0.04% | $459,459 |
| BARD ASSOCIATES INC | 1.1% | 118,003 | -2.6% | 0.09% | $421,271 |
| RENAISSANCE TECHNOLOGIES LLC | 0.71% | 77,504 | -22% | 0% | $276,689 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.65% | 70,263 | -3.7% | 0% | $250,916 |
| Mesirow Financial Investment Management, Inc. | 0.55% | 60,000 | -50% | 0% | $214,200 |
| HighTower Advisors, LLC | 0.55% | 59,710 | 0% | 0% | $213,165 |
| NAVELLIER & ASSOCIATES INC | 0.49% | 53,479 | +180% | 0.02% | $190,920 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.36% | 38,927 | -0.15% | 0.02% | $138,969 |
| VANGUARD FIDUCIARY TRUST CO | 0.34% | 36,901 | 0% | 0% | $131,737 |
| BLAIR WILLIAM & CO/IL | 0.33% | 36,249 | 0% | 0% | $129,409 |
| CITADEL ADVISORS LLC | 0.27% | 29,044 | +39% | 0% | $103,687 |
| DIMENSIONAL FUND ADVISORS LP | 0.2% | 22,164 | +6.8% | 0% | $79,126 |
| BlackRock, Inc. | 0.17% | 18,822 | 0% | $67,195 | |
| De Lisle Partners LLP | 0.16% | 17,400 | -30% | 0.01% | $62,118 |
| NORTHERN TRUST CORP | 0.15% | 16,706 | +54% | 0% | $59,640 |
| STATE STREET CORP | 0.14% | 15,698 | 0% | 0% | $56,042 |
| GOLDMAN SACHS GROUP INC | 0.12% | 12,836 | -9.4% | 0% | $45,825 |
| MERCER GLOBAL ADVISORS INC /ADV | 0.12% | 12,500 | 0% | $44,625 | |
| Cannell & Spears LLC | 0.1% | 11,000 | 0% | 0% | $39,270 |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 0.1% | 11,000 | -8.3% | 0.03% | $39,270 |
| UBS Group AG | 0.01% | 831 | 0% | $2,967 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
29
Headline period
Q2 2026
Rows shown
1-25 of 29
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 39,081 | $144,990 | +$15 | $3.71 | 2 |
| 2026 Q2 | 5,313,140 | $18,968,047 | -$195,903 | $3.57 | 33 |
| 2026 Q1 | 5,370,279 | $16,003,262 | -$119,431 | $2.98 | 27 |
| 2025 Q4 | 5,302,280 | $25,875,168 | +$1,403,304 | $4.88 | 35 |
| 2025 Q3 | 5,015,032 | $23,721,183 | +$770,357 | $4.73 | 23 |
| 2025 Q2 | 4,852,312 | $19,846,026 | +$767,466 | $4.09 | 20 |
| 2025 Q1 | 4,664,676 | $8,023,335 | -$71,094 | $1.72 | 17 |
| 2024 Q4 | 4,711,852 | $6,907,601 | +$947 | $1.47 | 17 |
| 2024 Q3 | 4,284,771 | $7,333,250 | -$66,476 | $1.71 | 17 |
| 2024 Q2 | 4,320,368 | $9,159,330 | +$116,985 | $2.11 | 18 |
| 2024 Q1 | 4,264,479 | $9,398,998 | -$169,208 | $2.19 | 18 |
| 2023 Q4 | 4,331,833 | $14,986,626 | +$148,381 | $3.46 | 18 |
| 2023 Q3 | 4,288,960 | $6,347,955 | +$12,732 | $1.48 | 14 |
| 2023 Q2 | 4,279,808 | $6,634,282 | +$34,065 | $1.55 | 15 |
| 2023 Q1 | 4,273,188 | $4,574,310 | +$8,159 | $1.07 | 17 |
| 2022 Q4 | 4,266,471 | $4,940,524 | -$78,172 | $1.16 | 18 |
| 2022 Q3 | 4,339,484 | $3,949,000 | +$17,380 | $0.91 | 17 |
| 2022 Q2 | 632,473 | $968,000 | -$108,653 | $1.53 | 15 |
| 2022 Q1 | 643,171 | $2,827,000 | -$4,636,503 | $4.39 | 13 |
| 2021 Q4 | 1,550,944 | $9,151,000 | -$931,227 | $5.90 | 11 |
| 2021 Q3 | 1,700,497 | $14,914,000 | +$362,427 | $8.77 | 13 |
| 2021 Q2 | 5,916,801 | $60,109,000 | +$672,777 | $10.15 | 15 |
| 2021 Q1 | 5,231,367 | $34,791,000 | -$660,885 | $6.65 | 17 |
| 2020 Q4 | 5,282,295 | $45,322,000 | +$2,352,286 | $8.58 | 14 |
| 2020 Q3 | 4,474,719 | $32,353,000 | -$269,921 | $7.23 | 15 |